Mission Based Media has announced the release of a new audio miniseries called Rethinking Alzheimer’s Disease on their Health UNMUTED platform. The miniseries aims to provide insights and information about the prevention and diagnosis of Alzheimer’s disease. It was created with support from Eisai Inc.
The 6-episode podcast will be launched at the American Academy of Neurology (AAN) Annual Meeting, which is being held in Denver, Colorado. The podcast is part of the Health UNMUTED audio library and is designed to bring hope and actionable insights to those affected by or concerned about Alzheimer’s. It will be available on all major podcast platforms and on HealthUnmuted.com.
Alzheimer’s disease affects approximately 6.7 million people in the U.S., with 500,000 new cases diagnosed each year. The Rethinking Alzheimer’s Disease podcast explains the development of Alzheimer’s and emphasizes the importance of early detection for more treatment options and future planning. Through the stories of patients, caregivers, and leading health experts, listeners will learn about diagnosis and how to seek support from healthcare providers.
The launch of Rethinking Alzheimer’s Disease coincides with the AAN Annual Meeting, which is the world’s largest gathering of neurologists and neuroscience professionals. The miniseries aims to raise awareness and provide valuable information about Alzheimer’s disease.
Dan Kendall, founder of Mission Based Media, stated that early stages of Alzheimer’s can begin years before symptoms appear, emphasizing the importance of proactive measures. He hopes that the miniseries will bring hope and actionable insights to those affected by or concerned about Alzheimer’s.
To listen to Rethinking Alzheimer’s Disease, visit the Health UNMUTED website or major podcast platforms. Mission Based Media is an integrated digital media company specializing in health content development, providing trustworthy and objective health information through podcasts and engaging conversations with experts and patients. For more information, visit missionbasedmedia.com.
Mission Based Media operates in the digital media industry, specializing in health content development. They aim to provide trustworthy and objective health information through their podcasts and engaging conversations with experts and patients.
The release of the new audio miniseries, Rethinking Alzheimer’s Disease, on their Health UNMUTED platform showcases their focus on providing insights and information about health-related topics. The miniseries is supported by Eisai Inc., a pharmaceutical company that focuses on developing treatments and solutions for neurological and neurodegenerative diseases.
Alzheimer’s disease is a significant health issue, affecting approximately 6.7 million people in the U.S. With 500,000 new cases diagnosed each year, it is crucial to raise awareness and provide valuable information about the disease. The Rethinking Alzheimer’s Disease podcast aims to do just that, emphasizing the importance of early detection for more treatment options and future planning.
The podcast will be launched at the American Academy of Neurology (AAN) Annual Meeting, which is the largest gathering of neurologists and neuroscience professionals in the world. This aligns with their goal of reaching a wide audience and spreading awareness about Alzheimer’s disease.
Dan Kendall, the founder of Mission Based Media, highlights the significance of proactive measures in dealing with Alzheimer’s disease. The miniseries aims to bring hope and actionable insights to those affected by or concerned about the disease.
To listen to Rethinking Alzheimer’s Disease and access other health-related content, individuals can visit the Health UNMUTED website or find the podcast on major podcast platforms.
For more information about Mission Based Media and their work in health content development, interested individuals can visit their website at missionbasedmedia.com.